Ehlers CL, Slutske WS, Lind P, Wilhelmsen KC (2007) Association between single nucleotide
polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in South West
California Indians. Twin Res Hum Gen 10:805– 811
ElSholy MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural
cannabinoids. Life Sci 78:539– 548
Fagan SG, Campbell VA (2012) The influence of cannabinoids on generic traits of neurodegen-
eration. Br J Pharmacol 171:1347– 1360
Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M (2006) Cannabinoid
CB2 receptor: a new target for controlling neural cell survival. Trends Pharmacol Sci 28:39– 45
Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire S, Le
Fur F, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human
immune tissues and leukocyte subpopulations. Eur J Biochem 232:54– 61
García-Gutiérrez MS, Ortega-Álvaro A, Busquets-GarcíaA,Pérez-Ortiz JM, Caltana L,
Ricatti MJ, Brusco A, Maldonado R, Manzanares J (2013) Synaptic plasticity alterations
associated with memory impairment induced by deletion of CB2 cannabinoid receptors.
Neuropharmacology 73:388– 396
Ghose H (2009) Cannabinoid controversy.http://www.the-scientist.com/news/display/55969/
Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M
(2004) Human brain endothelium: coexpression and function of vanilloid and endocannabinoid
receptors. Mol Brain Res 132:87– 92
Gong J-P, Onaivi ES, Ishiguro H, Liu Q-R, Tagliaferro PA, Brusco A, Uhl GR (2006)
Cannabinoid CB2 receptors: immunohistochemically localization in rat brain. Brain Res
1071:10– 23
Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME (1999)
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence
for CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 377:117– 125
Grimsey NL, Goodfellow CE, Scotter EL, Dowie MJ, Glass M, Graham ES (2008) Specific
detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal.
J Neurosci Methods 171:78– 86
Hillard CJ, Weinlander KM, Stuhr KL (2012) Contributions of endocannabinoid signaling to
psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204:207– 229
Horev G, Ellegood J, Lerch JP, Son YE, Muthuswamy L, Vogel H, Krieger AM, Buja A,
Henkelman RM, Wigler M, Mills AA (2011) Dosage-dependent phenotypes in models of
16p11.2 lesions found in autism. Proc Natl Acad Sci 108:17076– 17081
Ishiguro H, Iwasaki S, Teasenfitz L, Higuchi S, Horiuchi Y, Saito T, Arinami T, Onaivi ES (2007)
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in
humans. Pharmacogenomics J 7:380– 385
Ishiguro H, Carpio O, Horiuchi Y, Shu A, Higuchi S, Schanz N, Benno R, Arinami T, Onaivi ES
(2010a) A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with
eating disorders in humans and food intake is modified in mice by its ligands. Synapse 64:92–
96
Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, Morikawa M, Inada T,
Watanabe Y, Takahashi M, Someya T, Ujike H, Iwata N, Ozaki N, Onaivi ES, Kunugi H,
Sasaki T, Itokawa M, Arai M, Niizato K, Iritani S, Naka I, Ohashi J, Kakita A, Takahashi H,
Nawa H, Arinami T (2010b) Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry
67:974– 982
Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R,
Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS
(2015) Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in
immune cells. Acta Physiol 214:63– 74
Jesudason D, Wittert G (2008) Endocannabinoid system in food intake and metabolic regulation.
Curr Opin Lipidol 19:344– 348
Kannan G, Sawa A, Pletnikov MV (2013) Mouse models of gene-environment interactions in
schizophrenia. Neurobiol Dis 57:5– 11
244 E.S. Onaivi et al.